News

Biomarker-informed therapy guidance improved disease control rates among patients with inflammatory bowel disease (IBD) ...
Use of the investigational drug efruxifermin did not significantly reduce fibrosis in patients with compensated cirrhosis ...
Eli Lilly and Purdue University announced a $250 million in what the two institutions say is the largest industry-academic partnership in the country.
Market volatility and near-term uncertainty can be challenging to deal with these days -- or at any time. Let's consider four ...
The investment over the next eight years could be the largest ever industry-academic agreement of its kind in the U.S., the ...
Eli Lilly is investing more in its home state of Indiana, pumping up to $250 million more into an existing collaboration with ...
Eli Lilly and Purdue University expand their partnership with a $250 million investment to advance pharmaceutical innovation ...
Novo Nordisk's stock has plummeted over 60%, while also arguably losing market share to Eli Lilly. Click here to find out why ...
Over the next eight years, Eli Lilly and Company and Purdue University will continue their partnership. According to an announcement on Friday morning, Lilly is expected to ...
In an announcement made Friday, Lilly said they will invest up to $250 million through the “Lilly-Purdue 360” initiative over ...
NewLimit, an anti-aging biotech startup backed by Coinbase CEO Brian Armstrong, raised a $130 million Series B round.
This partnership, which officials said has the potential to be the largest ever U.S. industry-academic agreement of its kind, ...